HOME
ABOUT US
INVESTMENT STRATEGY
Venture
Growth Equity
Biopharma
Medical Devices
Healthcare Services
TEAM
Experience
Biographies
WORKING
WITH US
FAQ
PORTFOLIO
NEWS
Recent Financings
Clinical, Product and Corporate Developments
Frazier Healthcare Ventures In The News
CONTACT
Formed in 1991 to invest exclusively in emerging healthcare companies
Biopharma, Medical Devices and Healthcare Services
Experienced investment team with deep domain expertise
Building innovative healthcare companies while providing high returns
Over 85 companies funded; 21 public; 14 acquired
Over $1.8 billion of capital under management
Seattle Office
Two Union Square
601 Union Street
Suite 3200
Seattle, WA 98101
phone: 206-621-7200
Fax: 206-621-1848
Palo Alto Office
550 Hamilton Ave.
Suite 100
Palo Alto, CA 94301
Phone: 650-325-5156
Fax: 650-325-5157
RECENT FINANCINGS
Stromedix raises $25 million in a Series B financing round
April, 2008, Press Release
Tobira Therapeutics Inc. Completes $31 Millon Series A Financing and Names Management Team.
July, 2007, Press Release
Meda enters US Market Through Strategic Acquisition of MedPointe, Inc.
July, 2007, Press Release
CLINICAL, PRODUCT AND CORPORATE DEVELOPMENTS
QuatRx Pharmaceuticals Announces Positive Phase 3 Results For Study of Ophena
January, 2008, Press Release
Calistoga Pharmaceuticals Announces Completion of Its Series A Financing
January, 2008, Press Release
Macusight™ Announces Positive Initial Results From Phase One Study Of Sirolimus in Diabetic Macular Edema
October, 2007, Press Release
FRAZIER HEALTHCARE VENTURES IN THE NEWS
Frazier Healthcare Ventures Closes Sixth Institutional Fund
November, 2007, Frazier Healthcare Press Release
Senior Medical Device Executive is added to Frazier Healthcare’s Affiliate Investment Team
July, 2007, Frazier Healthcare Press Release
HOME
|
ABOUT US
|
INVESTMENT STRATEGY
|
TEAM
|
WORKING WITH US
|
PORTFOLIO
|
NEWS
|
CONTACT
Copyright 2005 Frazier Healthcare Ventures
